H.R. 6717 · 115th Congress
Depression Side Effect Labeling Awareness Act of 2018
- Stage
- In committee
- Sponsor
- Bobby Rush
- Introduced
- 2018-09-06
- Latest action
- 2018-09-06 · Introduced in House
Summary
Depression Side Effect Labeling Awareness Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to require the label of a drug that has an increased risk of suicide or depression to prominently display such risk.